Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion

Jiang Lei,Wang Mei,Liu PU,Liang Dong,Jiang-peng Wang,Hao-yu Meng,Xiang-Qing Kong,Lei-lei Chen

DOI: https://doi.org/10.1101/2024.06.05.24308526

2024-06-07

Abstract:Background: Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients. Methods: 258 consecutive patients with CTO lesions undergoing PCI at the First Affiliated Hospital of Nanjing Medical University from January 2011 to December 2017 were enrolled. After 25 were excluded due to CABG surgery, a total of 233 patients who met the enrollment criteria were divided into successful CTO-PCI group (n=187) and CTO-OMT group (n=46) based on the treatment received. The study primary endpoint was major adverse cardiac cerebrovascular events (MACCE), including cardiac death, recurrent myocardial infarction, unplanned revascularization, and stroke. The secondary endpoint was all-cause death. Results: During a median follow-up of 78 months, PCI treatment significantly improved MACCE incidence survival probability compared with OMT (29.55% vs 21.95% p=0.028). There was no difference between these two groups in secondary endpoint (p=0.93). There was also no significant difference in MACCE between single vessel CTO lesions and single vessel CTO combined with multiple vessel lesions(p=0.54). The cumulative survival of LAD is the highest among different branch lesion groups(p=0.044). Elderly patients (≥65 years) in PCI group showed a significant decrease of MACCE incidence compared with OMT (35.00% vs 21.33% p=0.001). Conclusions: Successful PCI in CTO patients is associated with a significant decrease of MACCE compared with OMT.

What problem does this paper attempt to address?

### Problems the paper attempts to solve

This paper aims to explore whether successful percutaneous coronary intervention (PCI) can improve the long - term clinical prognosis of patients with chronic total occlusion coronary artery disease (CTO). Compared with optimal medical therapy (OMT), whether PCI can significantly reduce the incidence of major adverse cardiac and cerebrovascular events (MACCE). Specifically, the research focuses on the following aspects:

1. **Primary endpoint**:
- Major adverse cardiac and cerebrovascular events (MACCE), including cardiac death, recurrent myocardial infarction, unplanned revascularization, and stroke.

2. **Secondary endpoint**:
- All - cause mortality.

3. **Research background**:
- Chronic total occlusion coronary artery disease (CTO) is considered a risk factor for increasing adverse clinical outcomes. Although PCI technology is constantly advancing, its efficacy in CTO patients remains controversial. Some observational studies have shown that successful CTO - PCI can bring better clinical results, especially the improvement of symptoms. However, the results of some randomized controlled trials (RCTs) are inconsistent, raising doubts about the benefits of CTO - PCI.

4. **Research objective**:
- Through a retrospective study, evaluate the impact of successful CTO - PCI on patient prognosis, especially the incidence of MACCE.

### Research methods

- **Research design**:
- Single - center, retrospective observational study.
- A total of 258 consecutive patients who received CTO - PCI in the First Affiliated Hospital of Nanjing Medical University from January 2011 to December 2017 were included.
- Exclusion criteria included ST - segment elevation myocardial infarction (STEMI), a history of coronary artery bypass grafting (CABG), cardiogenic shock, or malignant tumors.
- Finally, 233 eligible patients were included and divided into the successful CTO - PCI group (n = 187) and the CTO - OMT group (n = 46).

- **Statistical analysis**:
- The Kaplan - Meier method was used to draw survival curves, and the Log - rank method was used to compare the differences between the two groups.
- The Cox proportional - hazards regression model was used to detect independent risk factors for endpoint events.
- All data were analyzed using R software (version 4.3.1).

### Research results

- **Main findings**:
- During a median follow - up of 78 months, PCI treatment significantly increased the MACCE survival probability (29.55% vs 21.95%, p = 0.028), mainly due to the reduction in cardiac death (p = 0.045).
- In elderly patients aged 65 years and above, the incidence of MACCE was significantly reduced after PCI treatment (35.00% vs 21.33%, p = 0.001).

- **Secondary findings**:
- There was no significant difference in all - cause mortality between the two groups (p = 0.93).
- The recanalization rate of the left anterior descending artery (LAD) was the highest, and the cumulative survival rate was the highest (p = 0.044).

### Conclusion

- Compared with CTO - OMT, successful CTO - PCI significantly reduces the incidence of MACCE, especially more obvious in elderly patients. This indicates that CTO - PCI is an effective strategy to reduce the occurrence of MACCE and cardiac death.

### Limitations

- This study is a single - center retrospective observational study, and there may be selection bias.
- The sample size of the OMT group is small, and the incidences of death and myocardial infarction are low. Larger - scale multi - center prospective studies are required to further verify these results.
- With the rapid development of CTO - PCI technology and the accumulation of operator experience, the current success rate may be higher than that during the study period.
- Lack of myocardial nuclide imaging or cardiac magnetic resonance imaging, etc.